Logo image of BNRE

BROOKFIELD REINSURANCE LTD (BNRE) Stock Fundamental Analysis

NYSE:BNRE - New York Stock Exchange, Inc. - BMG162501057 - Common Stock - Currency: USD

47.12  -0.38 (-0.8%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to BNRE. BNRE was compared to 143 industry peers in the Insurance industry. BNRE has a medium profitability rating, but doesn't score so well on its financial health evaluation. BNRE is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

BNRE had positive earnings in the past year.
In the past year BNRE had a positive cash flow from operations.
BNRE had positive earnings in 4 of the past 5 years.
In the past 5 years BNRE always reported a positive cash flow from operatings.
BNRE Yearly Net Income VS EBIT VS OCF VS FCFBNRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 500M 1B 1.5B

1.2 Ratios

BNRE has a Return On Assets of 0.78%. This is in the lower half of the industry: BNRE underperforms 62.14% of its industry peers.
BNRE has a Return On Equity of 9.30%. This is comparable to the rest of the industry: BNRE outperforms 44.29% of its industry peers.
BNRE has a Return On Invested Capital (0.81%) which is in line with its industry peers.
Industry RankSector Rank
ROA 0.78%
ROE 9.3%
ROIC 0.81%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BNRE Yearly ROA, ROE, ROICBNRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 10 20 30

1.3 Margins

BNRE has a better Profit Margin (11.15%) than 70.71% of its industry peers.
BNRE's Profit Margin has improved in the last couple of years.
BNRE has a Operating Margin of 14.67%. This is in the better half of the industry: BNRE outperforms 66.43% of its industry peers.
BNRE's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 14.67%
PM (TTM) 11.15%
GM N/A
OM growth 3Y266.13%
OM growth 5YN/A
PM growth 3Y218.67%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BNRE Yearly Profit, Operating, Gross MarginsBNRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 5 10 15 20

More info and screens

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BNRE is destroying value.
There is no outstanding debt for BNRE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BNRE Yearly Shares OutstandingBNRE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 10M 20M 30M 40M 50M
BNRE Yearly Total Debt VS Total AssetsBNRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 10B 20B 30B 40B

2.2 Solvency

BNRE has a debt to FCF ratio of 2.54. This is a good value and a sign of high solvency as BNRE would need 2.54 years to pay back of all of its debts.
BNRE has a Debt to FCF ratio (2.54) which is in line with its industry peers.
A Debt/Equity ratio of 0.47 indicates that BNRE is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.47, BNRE is doing worse than 60.71% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 2.54
Altman-Z N/A
ROIC/WACC0.12
WACC6.8%
BNRE Yearly LT Debt VS Equity VS FCFBNRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 1B 2B 3B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
BNRE Yearly Current Assets VS Current LiabilitesBNRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 200M 400M 600M

More info and screens

4

3. Growth

3.1 Past

BNRE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -20.20%.
Measured over the past years, BNRE shows a very strong growth in Earnings Per Share. The EPS has been growing by 313.29% on average per year.
BNRE shows a strong growth in Revenue. In the last year, the Revenue has grown by 49.09%.
Measured over the past years, BNRE shows a very strong growth in Revenue. The Revenue has been growing by 111.15% on average per year.
EPS 1Y (TTM)-20.2%
EPS 3Y313.29%
EPS 5YN/A
EPS Q2Q%-75.61%
Revenue 1Y (TTM)49.09%
Revenue growth 3Y135.93%
Revenue growth 5Y111.15%
Sales Q2Q%48.59%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BNRE Yearly Revenue VS EstimatesBNRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2B 4B 6B

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 157.07, the valuation of BNRE can be described as expensive.
84.29% of the companies in the same industry are cheaper than BNRE, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 28.64, BNRE is valued quite expensively.
Industry RankSector Rank
PE 157.07
Fwd PE N/A
BNRE Price Earnings VS Forward Price EarningsBNRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

98.57% of the companies in the same industry are more expensive than BNRE, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 0.39
EV/EBITDA -5.76
BNRE Per share dataBNRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 200 400 600

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

1

5. Dividend

5.1 Amount

With a yearly dividend of 0.66%, BNRE is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.28, BNRE is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.52, BNRE's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.66%

5.2 History

BNRE has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
BNRE Yearly Dividends per shareBNRE Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

DP0%
EPS Next 2YN/A
EPS Next 3YN/A
BNRE Yearly Income VS Free CF VS DividendBNRE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 0 500M 1B 1.5B

More info and screens

BROOKFIELD REINSURANCE LTD

NYSE:BNRE (9/5/2024, 8:12:56 PM)

47.12

-0.38 (-0.8%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)08-08 2024-08-08/bmo
Earnings (Next)N/A N/A
Inst Owners1.48%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap795.38M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.66%
Yearly Dividend0.76
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 157.07
Fwd PE N/A
P/S 0.09
P/FCF 0.39
P/OCF 0.36
P/B 0.07
P/tB 0.09
EV/EBITDA -5.76
EPS(TTM)0.3
EY0.64%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)119.55
FCFY253.72%
OCF(TTM)129.39
OCFY274.59%
SpS539.4
BVpS646.81
TBVpS497.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.78%
ROE 9.3%
ROCE 1.03%
ROIC 0.81%
ROICexc 0.91%
ROICexgc 1.09%
OM 14.67%
PM (TTM) 11.15%
GM N/A
FCFM 22.16%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y266.13%
OM growth 5YN/A
PM growth 3Y218.67%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 2.54
Debt/EBITDA 3.5
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 5.61
Cash Conversion 149.38%
Profit Quality 198.82%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC6.8%
ROIC/WACC0.12
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.83%
Cap/Sales(5y)0.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-20.2%
EPS 3Y313.29%
EPS 5YN/A
EPS Q2Q%-75.61%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)49.09%
Revenue growth 3Y135.93%
Revenue growth 5Y111.15%
Sales Q2Q%48.59%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y18.76%
EBIT growth 3Y763.81%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y10.58%
FCF growth 3Y47.68%
FCF growth 5Y55.77%
OCF growth 1Y19.21%
OCF growth 3Y52.3%
OCF growth 5Y58.72%